SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 12, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed4d 6h ago
Insider cluster: 2 insiders, $103K total
Actionable Insight • Neutral

The dollar value of insider sales is negligible relative to market cap, indicating routine portfolio diversification rather than a negative signal. Monitor next earnings release for any operational updates that could affect the stock's volatility.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$11.83
T+0 close · Nov 12, 2026 · via day close
Latest settled
−4.48%
T+1 · $11.30
Vs SPY
−2.57%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $11.83entry
  2. T+1 · 16h ago −4.48%α −2.57% · $11.30
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two NovoCure insiders, including the CFO and CHRO, sold shares in open-market transactions totaling $103K over a one-week period. The sales are small relative to the company's $1.4B market cap (0.007%), making them routine and not indicative of material non-public information.

Key Financial Metrics

Direction
selling
Total Value
$103.0K
Insiders
2

Key Facts

  • CFO Brackmann Christoph sold 7,343 shares at $12.86 for $94K on Nov 9, 2026
  • CHRO Puri Michal Nath sold 660 shares at $13.24 for $9K on Nov 2, 2026
  • Total open-market sales by insiders: $103K, or 0.007% of market cap
  • Neither sale was executed under a 10b5-1 plan
  • No insider purchases were reported in the cluster window

Financial Impact

Total insider sales of $103K, immaterial relative to $1.4B market cap

Risk Factors

  • Insider sales, while small, could be perceived negatively by retail investors if highlighted out of context
  • No insider buying to offset the selling pattern

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NVCR-1794517751336

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Viewing Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026